Cutaneous T-cell lymphomas (CTCLs) make up about 4% of non-Hodgkin lymphomas and the NRAS Q61K mutation in Hut78 cells has been determined as a significant oncogenic factor in CTCL development [16]. The gene discussed is NRAS; the disease is non-Hodgkin lymphoma.